JP2025513066A5 - - Google Patents

Info

Publication number
JP2025513066A5
JP2025513066A5 JP2024560442A JP2024560442A JP2025513066A5 JP 2025513066 A5 JP2025513066 A5 JP 2025513066A5 JP 2024560442 A JP2024560442 A JP 2024560442A JP 2024560442 A JP2024560442 A JP 2024560442A JP 2025513066 A5 JP2025513066 A5 JP 2025513066A5
Authority
JP
Japan
Prior art keywords
nucleic acid
rna
sequence
expression cassette
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024560442A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/059507 external-priority patent/WO2023198745A1/en
Publication of JP2025513066A publication Critical patent/JP2025513066A/ja
Publication of JP2025513066A5 publication Critical patent/JP2025513066A5/ja
Pending legal-status Critical Current

Links

JP2024560442A 2022-04-12 2023-04-12 Apoeの核酸制御 Pending JP2025513066A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP22167926 2022-04-12
EP22167926.9 2022-04-12
EP22200272 2022-10-07
EP22200272.7 2022-10-07
EP23162681 2023-03-17
EP23162681.3 2023-03-17
PCT/EP2023/059507 WO2023198745A1 (en) 2022-04-12 2023-04-12 Nucleic acid regulation of apoe

Publications (2)

Publication Number Publication Date
JP2025513066A JP2025513066A (ja) 2025-04-22
JP2025513066A5 true JP2025513066A5 (https=) 2026-04-20

Family

ID=85873819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560442A Pending JP2025513066A (ja) 2022-04-12 2023-04-12 Apoeの核酸制御

Country Status (5)

Country Link
US (1) US20250223590A1 (https=)
EP (1) EP4508213A1 (https=)
JP (1) JP2025513066A (https=)
CN (1) CN119032174A (https=)
WO (1) WO2023198745A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4065600A1 (en) 2019-11-25 2022-10-05 Cornell University Apoe gene therapy
WO2025090631A1 (en) * 2023-10-23 2025-05-01 The Children's Hospital Of Philadelphia Aav vectors for delivery of apoe2
WO2025213111A2 (en) * 2024-04-05 2025-10-09 Cornell University Aav expression of mirna to suppress human apoe mrna
WO2025219443A1 (en) * 2024-04-19 2025-10-23 Uniqure Biopharma B.V. Nucleic acid for a1at regulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
EP2311966A3 (en) 2005-10-20 2012-09-05 Amsterdam Molecular Therapeutics (AMT) B.V. Improved AAV vectors produced in insect cells
CN103849629B (zh) 2006-06-21 2017-06-09 尤尼克尔Ip股份有限公司 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体
DK2173888T3 (en) 2007-07-26 2016-11-28 Uniqure Ip Bv Baculovirus vectors comprising repeating coding sequences WITH differential preferred codons
JP2011512156A (ja) 2008-02-19 2011-04-21 アムステルダム モレキュラー セラピューティクス ビー.ブイ. 昆虫細胞におけるパルボウイルスrep及びcapタンパク質の発現の最適化
WO2011122950A1 (en) 2010-04-01 2011-10-06 Amsterdam Molecular Therapeutics (Amt) Ip B.V. Monomeric duplex aav vectors
JP6198278B2 (ja) 2011-09-08 2017-09-20 ユニキュアー アイピー ビー.ブイ. Aav調製物からの混入ウイルスの除去
CA2942289C (en) 2014-03-10 2024-05-21 Uniqure Ip B.V. Further improved aav vectors produced in insect cells
HRP20190992T1 (hr) 2014-12-24 2019-09-20 Uniqure Ip B.V. Suprimiranje gena za huntingtin inducirano s rnai
EP3655538A1 (en) 2017-07-20 2020-05-27 uniQure IP B.V. Improved aav capsid production in insect cells
JP2023500793A (ja) * 2019-10-16 2023-01-11 コーネル・ユニバーシティー アルツハイマー病に対する遺伝子治療方法
EP4065600A1 (en) * 2019-11-25 2022-10-05 Cornell University Apoe gene therapy

Similar Documents

Publication Publication Date Title
JP2025513066A5 (https=)
JP7416443B2 (ja) 高形質導入効率rAAVベクター、組成物、および使用方法
US9611302B2 (en) High-transduction-efficiency RAAV vectors, compositions, and methods of use
JP2022530544A5 (https=)
JP2023529315A (ja) 機能的aavカプシドのハイスループット工学操作
JP2021534809A (ja) Aavカプシドの向性の再指向化
JP2022530633A5 (https=)
CN115023242A (zh) 腺相关病毒载体变体
JP2022517174A5 (https=)
JP2022530656A5 (https=)
JP2021515548A5 (https=)
AU2023217698A1 (en) Aav capsid variants and uses thereof
JP2021502060A5 (https=)
JP2022531861A5 (https=)
JP2023524291A5 (https=)
JP2023537625A5 (https=)
US20220380798A1 (en) AAV Expression Cassette and AAV Vectors Comprising the Same
WO2021034222A9 (ru) Выделенный модифицированный белок vp1 капсида aav5
JP2022511453A5 (https=)
JP2023500793A5 (https=)
WO2025038430A1 (en) Aav capsid variants and uses thereof
JP2024542950A5 (https=)
JP2023551254A5 (https=)
US20230346978A1 (en) Dcas13-mediated therapeutic rna base editing for in vivo gene therapy
US20250025575A1 (en) Compositions and Methods for Cell-Specific Expression of Target Genes